Introduction
ymic neoplasms are responsible for 0.2 to 1.5% of total tumor incidence and are the most common neoplasms arising in the anterior mediastinum in adults [1] . ey include both thymomas (20% of mediastinal neoplasms) and thymic carcinomas. Most thymoma patients are between 40 and 60 years of age, and there is a slight male predominance.
ere are no known risk factors, and there is a strong association with paraneoplastic syndromes, the most common being myasthenia gravis (MG). MG has been diagnosed in 30 to 40 percent of thymic neoplasms; other paraneoplastic syndromes are rare [2] . MG is a neuromuscular junction disorder caused by an autoimmune reaction to the acetylcholine receptors of striated muscle; symptoms include diplopia, ptosis, dysphagia, weakness, and fatigue. Up to 50% of patients with thymoma have symptoms consistent with MG, which is common in all types of thymoma but is rare in thymic carcinoma; there is no sex predominance. Patients with thymoma and MG usually present with less advanced disease than those without MG, possibly because neuromuscular symptoms lead to an earlier diagnosis.
ymectomy usually results in reduction of the severity of myasthenia, although symptoms may persist in most patients.
Kaposi sarcoma (KS) is an angioproliferative disorder that requires infection with human herpesvirus 8 (HHV-8) for its development. As many as 4-15% of the healthy population may be seropositive for HHV-8; however, only under certain circumstances does KS develop, namely, in immunocompromised patients. KS is classi ed into four types based on the clinical ground in which it develops: (1) classic (the type originally described by Kaposi, a ecting the oral cavity and skin, typically presenting in middle-or old-aged patients); (2) endemic (several forms described in sub-Saharan indigenous Africans prior to AIDS epidemic); (3) iatrogenic (associated with immunosuppressive drug therapy, usually diagnosed in renal allograft recipients); and (4) AIDS-associated (epidemic KS) [3] .
In recent literature, some cases of association between KS and thymoma have been reported, most of them with cytopenia secondary to the thymic neoplasm (either pure red cell aplasia, erythroblastopenia, CD4+ lymphopenia, or Good syndrome-combined B and T cell immunode ciency). Some reported cases include KS in HIV-negative patients, some in unique presentation sites [4] [5] [6] [7] [8] .
Case Report
We report the case of a male patient aged 46. e patient had been diagnosed with MG at age 26, when symptoms of facial and limb extremities weakness were noticed for the rst time. Following investigation, a thymoma was found as the cause of MG, and at age 32, he was submitted to a thymectomy and treated with acetylcholinesterase inhibitors and immunosuppressants, namely, corticosteroids.
At the age of 45, the patient was referred for the rst time with complaints of facial pain in the right malar region and purulent nasal discharge from the same side. He was clinically diagnosed with acute sinusitis and underwent medical treatment, with slight relief of symptoms. As symptoms persisted after medical management, a CT scan was ordered, revealing an expansive maxillary sinus opaci cation with erosion of the right maxillary sinus medial wall (Figure 1 ). e magnetic resonance imaging (MRI) revealed a mass in the right maxillary sinus with an heterogeneous pattern in the T1 sequence with contrast ( Figure 2 ).
An endoscopy for biopsy purposes was performed, but it was inconclusive due to clinically relevant hemorrhage from a vascularized lesion protruding in the medial wall of the maxillary sinus. An angiography and preoperative embolization (Figure 3 ) of the right sphenopalatine artery was undertaken, and a meatotomy and ethmoidectomy under endoscopic control were performed (Figures 4 and 5) . Unexpectedly, the histologic result was a kaposiform hemangioendothelioma, a proliferation of endothelial fusiform cells, considered to be nearly exclusive of children and teenagers.
e patient remained stable with only symptomatic treatment until the age of 50 when, following worsening of MG symptoms (speci cally astenia and fatigue), metastatic lung deposits of the thymoma were diagnosed. Surgical removal of the metastasis was undertaken.
e thymoma was classi ed as a B3 (WHO, 1999), and therefore, the patient was also treated with adjuvant radiotherapy. During radiotherapy and due to worsening of MG symptoms, human immunoglobulin and corticosteroids were administered. Case Reports in Otolaryngology ree months after these events, the patient had a new relapse from his MG and started corticotherapy. Two weeks into the treatment, he referred to newly skin pigmentation on the left wrist and legs. He also stated that these skin lesions were present 3 months earlier but smaller in size, growing with the recently added immunosuppressant therapy. ese lesions were biopsied, and the histologic result was Kaposi sarcoma (KS).
e patient was found to be HHV-8 IgG positive and HIV 1/2 and HTLV I/II negative.
Discussion
It was the diagnosis of KS in the biopsy of the limbs' lesions that led us to rethink the previous nding of the maxillary sinus kaposiform hemangioendothelioma, since the latter is usually not associated with HHV-8 IgG positivity nor is seen in adults. An histological review of the operatory sample was performed, and with immunohistochemistry technique (not previously available in the hospital), it was rediagnosed as a KS of the maxillary sinus.
KS in paranasal sinuses has been reported extensively in the literature, however, always associated with HIV infection or with immunosuppressant therapy. KS associated with hematologic, lymphoid, and thymic neoplasia has also been described, but no cases have been reported in the paranasal sinuses [9] . e KS in the extremities was most probably associated with the immunosuppressant therapy, since it developed right after the beginning of corticotherapy.
Extensive research on the characteristics of the paranasal sinus histology was undertaken, in order to explain the propensity of the maxillary sinus to develop KS (in both HIV-positive and HIV-negative patients) compared to the other paranasal cavities. No di erences between maxillary sinus and the other paranasal sinuses were found to be signi cant in the literature to explain this propensity, and therefore it is still an open subject for further investigation.
Conclusion
Using the words "kaposi," "sarcoma," "maxillary sinus," "HIV," and "HIV negative" in di erent combinations in the databases PubMed/MEDLINE and Cochrane Database of Systematic Reviews (Issue 4 of 12, April 2014), there were no ndings of cases in the recent literature of a maxillary sinus KS in an HIVnegative patient. erefore, the authors here present what is thought to be the rst described case of a maxillary sinus KS in an HIV-negative patient. We alert for care in the di erential diagnosis of paranasal sinus lesions if concomitant with a thymoma, because the immunosuppressive treatment of the second, or the disease itself, can cause the development of the KS, regardless of an associated HIV infection.
ere is still the need to keep investigating the speci c features of the maxillary sinus that lead it to be more susceptible to these lesions.
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